AtriCure, Inc. (ATRC): Operating Cash Flow
$57.33M
Year ended 2025-12-31
$64.94M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $57.33M | +369.8% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $12.20M | +172.2% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $4.48M | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$22.14M | n/m | 2025-02-14, From 2022-01-01 |
| 2021-12-31 | -$13.78M | n/m | 2024-02-16, From 2021-01-01 |
| 2020-12-31 | -$19.87M | n/m | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | -$15.81M | n/m | 2022-02-17, From 2019-01-01 |
| 2018-12-31 | -$4.17M | n/m | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | -$8.94M | n/m | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | -$15.12M | n/m | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | -$7.84M | n/m | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | -$21.60M | n/m | 2017-03-08, From 2014-01-01 |
| 2013-12-31 | -$5.22M | n/m | 2014-03-11, From 2013-01-01 |
| 2012-12-31 | -$1.94M | n/m | 2014-03-11, From 2012-01-01 |
| 2011-12-31 | -$1.99M | n/m | 2014-03-11, From 2011-01-01 |
| 2010-12-31 | -$33.0K | n/c | 2013-03-08, From 2010-01-01 |
| 2009-12-31 | $419.9K | n/a | 2012-03-12, From 2009-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| AtriCure, Inc. (ATRC) | 2025-12-31 | $57.33M | +369.8% |
| Glaukos Corp (GKOS) | 2025-12-31 | -$14.79M | n/m |
| Bioventus Inc. (BVS) | 2025-12-31 | $74.67M | +92.5% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $91.91M | +38.0% |
| Artivion, Inc. (AORT) | 2025-12-31 | $39.88M | +79.3% |
| NovoCure Ltd (NVCR) | 2025-12-31 | -$49.03M | n/m |
| Mimedx Group, Inc. (MDXG) | 2025-12-31 | $74.00M | +11.8% |
| Accuray Inc (ARAY) | 2026-06-30 | -$6.98M | n/m |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $80.86M | n/m |
Compare ATRC, GKOS, BVS, UFPT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗